Vantage Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$23M |
| 2 |
lululemon athletica
LULU
|
+$16.5M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$13.9M |
| 4 |
Northrop Grumman
NOC
|
+$12.5M |
| 5 |
Watsco Inc
WSO
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$38.4M |
| 2 |
Walt Disney
DIS
|
+$29.7M |
| 3 |
Honeywell
HON
|
+$13.6M |
| 4 |
Texas Instruments
TXN
|
+$13.3M |
| 5 |
Warner Bros
WBD
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.57% |
| 2 | Healthcare | 19.89% |
| 3 | Technology | 15.4% |
| 4 | Industrials | 10.65% |
| 5 | Financials | 6.1% |
Similar funds
Vantage Investment Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Vantage Investment Partners held 70 positions worth $1.12B, up 12% from $1B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Vantage Investment Partners deployed $50.4M of net new capital in Q1 2024, opening 5 new positions and adding to 22 existing holdings. Its largest new stake was Watsco Inc: 29,949 shares worth $12.9M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Eli Lilly, an estimated $6.57M trimmed.
- Vantage Investment Partners's largest Q1 2024 buy was Watsco Inc: 29,949 shares worth $12.9M.
- Vantage Investment Partners added most to UnitedHealth in Q1 2024, an estimated $23M increase.
- Vantage Investment Partners's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $6.57M.
- Vantage Investment Partners fully exited Chevron in Q1 2024, selling an estimated $38.4M.
- Vantage Investment Partners's ten largest holdings make up 47% of its $1.12B portfolio in Q1 2024.
- Vantage Investment Partners opened 5 new positions and closed 8 in Q1 2024.
- Vantage Investment Partners's portfolio value rose 12% quarter-over-quarter to $1.12B.
Based on Vantage Investment Partners's 13F filing for Q1 2024, filed 30 Apr 2024.